- RockNTix takes on the ticketing monopoly with a view to abolishing service fees - 163
- Country Artist Ashley Wineland to Release Poignant Ballad 'I'm Going Home'; Announces Her 2023 National Tour
- San Jose: : San José's Chief Building Official Chu Chang Honored as California Building Official of the Year
- On his first day in office, Governor Newsom signed an executive order to bring down the cost of prescription drugs by leveraging California's market power.
- California signed a contract with CIVICA to manufacture affordable insulin
- The Governor will seek to manufacture Naloxone through CalRx
DOWNEY, CA – Governor Gavin Newsom, as part of his tour of the State of California, announced that CalRx has secured a contract with a manufacturer (CIVICA), to make $30 insulin available to all who need it. The Governor also announced today that California will seek to manufacture its own Naloxone.
Today's announcement makes good on Governor Newsom's promise on his first day in office, to bring down the price of prescription drugs for Californians and increase accountability and transparency in health care. Californians can learn more about CalRX on the newly launched website.
More on The Californer
- Murder on the Links WORLD PREMIERE at North Coast Repertory Theatre
- Ferocious Talent Management Europe Celebrates the Fifth Grammy Win For Our Very Own Rob Chiarelli At
- Majority Of Medicare Advantage Plans Offer Added Benefits
- California: Governor Newsom Announces Appointments 3.24.23
- California Continues Creating Jobs
WHAT GOVERNOR NEWSOM SAID: "People should not be forced to go into debt to get life saving prescriptions. Through CalRx, Californians will have access to some of the most inexpensive insulin available, helping them save thousands each year. But we're not stopping there – California will seek to make our own Naloxone as part of our plan to fight the fentanyl crisis."
WHY THIS MATTERS: Today's announcement will bring down the price of insulin by about 90%, saving cash-paying patients between $2,000 and $4,000 annually. With CalRx, and unlike private companies, we're getting at the underlying cost – the price is the price, and CalRx will prevent the egregious cost-shifting that happens in traditional pharmaceutical price games. It'll cost us $30 to manufacture and distribute, and that's how much the consumer can buy it for. You don't need a voucher or coupon to access this price, and it's available to everybody regardless of insurance plan. This is a crucial step in not just cutting the cost for the consumer, but cutting costs across the board in order to bring cheaper prescription drugs to all Californians.
"To address the affordability crisis in California, we have to address the high cost of prescription drugs," said Dr. Mark Ghaly, Secretary of the California Health and Human Services Agency. "The CalRx Biosimilar Insulin Initiative will benefit Californians who are today paying too much for a medication that we know is life saving and life altering."
More on The Californer
- California: Governor Newsom Eases Drought Restrictions
- California: Governor Newsom Announces Appointments 3.23.23
- California: What They're Saying: Governor Newsom's Proposal to Hold Big Oil Accountable
- California: Governor Newsom Signs Legislation 3.23.23
- Matt Fogelgren to Join Cleartelligence Executive Team as Chief Revenue Officer
- A 10mL vial will be made available for no more than $30 (normally $300)
- A box of 5 pre-filled 3mL pens will be made available for no more than $55 (normally more than $500)
- No new prescription will be needed. Californians will be able to ask for the CalRx generic at their local pharmacy or via mail order pharmacies. Pharmacies must agree to order/stock the product.
- CalRx plans to make biosimilar insulins available for: Glargine, Aspart, and Lispro (expected to be interchangeable with Lantus, Humalog, and Novolog respectively)
WHAT COMES NEXT
- As part of the State's Master Plan to Tackle the Fentanyl Crisis, California is exploring potential next products to bring to market, like Naloxone, to aid in the State's effort to combat fentanyl overdoses.
- CIVICA is working with the California Health and Human Services Agency to identify a California-based manufacturing facility
Filed Under: Government, State
Latest on The Californer
- 2023 National Farmworker Awareness Week
- Orbex Introduces Double Profits for New Traders
- Against All Odds: University of California Berkeley Men's Cricket Team Lifts NCCA Cup
- Tech N9ne Surprises Kxng Crooked Interview with I Only Touch Greatness
- Quotehunt.co.uk: Revolutionising the UK B2B Market with Comprehensive Comparison Services for Small Businesses
- The 2nd Aollywood Five Continents Film Festival Nominations Were Announced: "All Quiet on the Western Front" Led With 7 Nominations
- Human Matriptase/ST14 Protein (High Purity)
- Myristoyl-Coenzyme A (Highly Pure)
- Dr. Kelli Ward and Martha Boneta Fain join the advisory board of Legacy PAC , a partner of Veterans for Trump
- My Refuge House Hosts Much Ado for Freedom
- 2023 Employee Handbook Templates Now Available
- Passive Income for Retirees - Income Ideas for Retirees
- Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Stanley Black & Decker, Inc. (SWK)
- Mercy Street to Host the Largest Opening Day Event in the Organization's 20 Year History
- The Nashville International Chopin Piano Competition Announces the Alexei Sultanov Memorial Discovery Prize
- Available Medicare Advantage Plans 2023 Increased By 6 Percent
- Kobie Voted a Top Workplace USA
- Aquia Inc. Joins the AWS Partner Network and the AWS Public Sector Partner Program
- PatientClick launched Hybrid Medical Billing Services
- Perfect Body Laser and Aesthetics ® Offers Tetra CoolPeel Co2 Laser Skin Resurfacing